基线舒张压对标准降压和强化降压效果的影响

作     者：Beddhu S Chertow GM Cheung AK Cushman WC Rahman M Greene T Wei G Campbell RC Conroy M Freedman BI Haley WE Horwitz EJ Kitzman DW Lash J Papademetriou V Pisoni R Riessen E Rosendorff C Watnick SG Whittle J Whelton PK 

作者机构：Medical Service Veterans Affairs Salt Lake City Health Care System UT (S.B. A.K.C.) Division of Nephrology and Hypertension (S.B. A.K.C. G.W.) Division of Biostatistics (T.G.) Division of General Internal Medicine (M.C.) University of Utah School of Medicine Salt Lake City. Stanford University Palo Alto CA (G.M.C.) Veterans Affairs Medical Center Memphis TN (W.C.C.) Case Western Reserve University Cleveland OH (M.R. E.H.) Medical University of South Carolina Charleston (R.C.C. R.P.) Section on Nephrology (B.I.F.) Section on Cardiology (D.K.) Wake Forest School of Medicine Winston-Salem NC. Division of Nephrology and Hypertension Mayo Clinic Jacksonville FL (W.H.) Metrohealth Medical Center Cleveland OH (E.H.) University of Illinois at Chicago IL (J.L.) Division of Cardiology Veterans Administration Medical Center Washington DC (V.P.) Ralph H. Johnson VA Medical Center Charleston SC (R.P.) Intermountain Medical Center Murray UT (E.R.) Icahn School of Medicine at Mount Sinai New York NY (C.R.) Oregon State Health University Portland (S.G.W.) Primary Care Division Clement J. Zablocki VA Medical Center Milwaukee WI (J.W.) Tulane University School of Public Health and Tropical Medicine New Orleans LA (P.K.W.). 

出 版 物：《中华高血压杂志》 (Chinese Journal of Hypertension)

年 卷 期：2017年第25卷第12期

页      面：1182-1184页

核心收录：

学科分类：1002[医学-临床医学] 100201[医学-内科学(含：心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学] 

基　　金：NIDDK NIH HHS,R21 DK106574 NCRR NIH HHS,UL1 RR024134 NCATS NIH HHS,UL1 TR000105 NCATS NIH HHS,UL1 TR000002 NIDDK NIH HHS,R01 DK091437 NCRR NIH HHS,UL1 RR025755 NCRR NIH HHS,C06 RR011234 NCATS NIH HHS,UL1 TR000073 NCATS NIH HHS,UL1 TR000439 NCATS NIH HHS,UL1 TR000050 NCATS NIH HHS,UL1 TR000003 NHLBI NIH HHS,HHSN268200900047C NHLBI NIH HHS,HHSN268200900049C NCATS NIH HHS,UL1 TR000093 NCRR NIH HHS,UL1 RR025771 NCRR NIH HHS,UL1 RR025752 NCATS NIH HHS,UL1 TR001064 NIGMS NIH HHS,P30 GM103337 NCATS NIH HHS,UL1 TR000075 NCRR NIH HHS,UL1 RR025764 NCATS NIH HHS,UL1 TR000064 NHLBI NIH HHS,HHSN268200900046C NHLBI NIH HHS,HHSN268200900040C NCATS NIH HHS,UL1 TR000005 NHLBI NIH HHS,HHSN268200900048C NCATS NIH HHS,UL1 TR000445 NCATS NIH HHS,UL1 TR000433 

主　　题：降压效果 舒张压 标准 基线 随机对照试验 终末期肾病 心血管病 血压升高 

摘      要：血压升高是心血管病、终末期肾病（end—stage kidney disease，ESKD）和全因死亡的一个重要危险因素。自20世纪60年代开始，随机对照试验证明了治疗高舒张压，随后又证明了治疗高收缩压的价值。